Crestforge
Engineering the Next Generation of Molecular Testing
Overview
CrestForge is the R&D and manufacturing platform within the G3 Genomics portfolio. It develops advanced molecular diagnostics technologies and provides contract manufacturing services for reagent kits and molecular products. CrestForge operates at the intersection of innovation and production — bringing new platforms from concept to commercial readiness while running quality manufacturing operations for internal and external partners.
Research & Development
NICER platform
NICER is a proprietary molecular diagnostics technology under development at CrestForge. Designed as a simpler, faster, and more accessible alternative to conventional PCR‑based workflows, NICER targets the large and growing point‑of‑need diagnostics market. The platform is supported by a PCT application and has received an independent greenfield assessment from patent counsel.
Research & Development
NGS library prep
CrestForge holds two issued U.S. patents with corresponding international patent families covering NGS library preparation methods. This IP underpins commercial kit development across the portfolio and creates licensing and partnership opportunities
Who We Serve
CrestForge CMO services are designed for diagnostics companies launching new assay panels, biotech companies with validated assays seeking production‑scale manufacturing, and established IVD companies looking for a quality‑focused manufacturing partner.
Contract Manufacturing & Services
Custom reagent formulation for qPCR, NGS, and isothermal applications
- End‑to‑end kit assembly, packaging, and labeling with full traceability
- Private‑label and white‑label manufacturing for life science and diagnostics companies
- ·Scale‑up support from pilot lots to routine production
- Quality‑documented processes and cold‑chain fulfillment
CrestForge is a separate legal entity within the G3 portfolio, serving both internal portfolio companies and external clients under defined quality and confidentiality frameworks
Bandit Bio (Bandit biosystems inc)
SeqOnce™ qPCR and NGS Kits Built for Real‑World Labs
Overview
Bandit Bio develops and commercializes SeqOnce™ qPCR assay panels and NGS library preparation kits for research and clinical laboratories. Our products are built by scientists who understand the pressures of laboratory throughput, turnaround time, and data quality — and designed to perform where it matters most: consistently, at scale, in working labs
Product Lines
SeqOnce™ qPCR Panels
Multiplex assay panels for respiratory and infectious disease, women's health and STI targets, veterinary applications, and custom research panels. Designed for compatibility with standard qPCR platforms and straightforward LDT validation workflows.
SeqOnce™ NGS Library Prep Kits
Library preparation chemistries that reduce hands‑on time, simplify workflows, and lower cost per sample while maintaining high library quality. Optimized for whole genome sequencing and adaptable for amplicon, cfDNA, and custom applications.
Business Model
Bandit Bio operates on a consumables model — recurring reagent revenue with high gross margins and an expanding product menu that grows customer value over time.
Support
Application notes, protocols, and scientist‑to‑scientist technical support are available to help labs move from evaluation to routine use efficiently.
Bandit Bio is a separate legal entity within the G3 portfolio, serving both internal portfolio companies and external clients under defined quality and confidentiality frameworks